DBV Technologies S.A.

Direct answer

DBV Technologies S.A. is publicly traded on NASDAQ under the ticker DBVT.

DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase III clinical trials as an immunotherapy for peanut allergies in children aged 4 to 11, adolescents, and adults. The company's pipeline also includes Viaskin Milk,...

Can you invest in DBV Technologies S.A.?

Yes. DBV Technologies S.A. is publicly traded on NASDAQ under the ticker DBVT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for DBV Technologies S.A.

Detailed equity research is provided by MarketSnap.